336 related articles for article (PubMed ID: 15570655)
1. Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus.
Gordon P; Khamashta MA; Rosenthal E; Simpson JM; Sharland G; Brucato A; Franceschini F; De Bosschere K; Meheus L; Meroni PL; Hughes GR; Buyon J
J Rheumatol; 2004 Dec; 31(12):2480-7. PubMed ID: 15570655
[TBL] [Abstract][Full Text] [Related]
2. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
[TBL] [Abstract][Full Text] [Related]
3. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
4. Limiting dilution analysis of Epstein-Barr virus infectable B cells secreting anti-Ro/SSA and anti-La/SSB antibodies in neonatal lupus erythematosus and systemic lupus erythematosus.
Isacovics B; Silverman ED
J Autoimmun; 1993 Aug; 6(4):481-94. PubMed ID: 8216690
[TBL] [Abstract][Full Text] [Related]
5. Maternal antibody responses to the 52-kd SSA/RO p200 peptide and the development of fetal conduction defects.
Clancy RM; Buyon JP; Ikeda K; Nozawa K; Argyle DA; Friedman DM; Chan EK
Arthritis Rheum; 2005 Oct; 52(10):3079-86. PubMed ID: 16200587
[TBL] [Abstract][Full Text] [Related]
6. Relationship between maternal and neonatal levels of antibodies to 48 kDa SSB(La), 52 kDa SSA(Ro), and 60 kDa SSA(Ro) in pregnancies complicated by congenital heart block.
Buyon JP; Waltuck J; Caldwell K; Crawford B; Slade SG; Copel J; Chan EK
J Rheumatol; 1994 Oct; 21(10):1943-50. PubMed ID: 7837164
[TBL] [Abstract][Full Text] [Related]
7. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
[TBL] [Abstract][Full Text] [Related]
8. Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring.
Stea EA; Routsias JG; Clancy RM; Buyon JP; Moutsopoulos HM; Tzioufas AG
Arthritis Rheum; 2006 Jul; 54(7):2228-34. PubMed ID: 16802359
[TBL] [Abstract][Full Text] [Related]
9. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of mothers of children with complete congenital heart block.
Press J; Uziel Y; Laxer RM; Luy L; Hamilton RM; Silverman ED
Am J Med; 1996 Mar; 100(3):328-32. PubMed ID: 8629679
[TBL] [Abstract][Full Text] [Related]
11. [Immunoresponse to SS-A 52-kDa and 60-kDa proteins in mothers of infants with neonatal lupus erythematosus].
Miyano A; Nakayama M; Waguri M; Fujita T
Rinsho Byori; 2008 Dec; 56(12):1081-5. PubMed ID: 19175071
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune response in mothers of children with congenital and postnatally diagnosed isolated heart block: a population based study.
Julkunen H; Miettinen A; Walle TK; Chan EK; Eronen M
J Rheumatol; 2004 Jan; 31(1):183-9. PubMed ID: 14705240
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies.
Spence D; Hornberger L; Hamilton R; Silverman ED
J Rheumatol; 2006 Jan; 33(1):167-70. PubMed ID: 16292791
[TBL] [Abstract][Full Text] [Related]
14. Long-term followup of children with neonatal lupus and their unaffected siblings.
Martin V; Lee LA; Askanase AD; Katholi M; Buyon JP
Arthritis Rheum; 2002 Sep; 46(9):2377-83. PubMed ID: 12355485
[TBL] [Abstract][Full Text] [Related]
15. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies.
Buyon JP; Winchester RJ; Slade SG; Arnett F; Copel J; Friedman D; Lockshin MD
Arthritis Rheum; 1993 Sep; 36(9):1263-73. PubMed ID: 8216420
[TBL] [Abstract][Full Text] [Related]
16. Neonatal lupus erythematosus in Japan: a review of the literature.
Kobayashi R; Mii S; Nakano T; Harada H; Eto H
Autoimmun Rev; 2009 May; 8(6):462-6. PubMed ID: 19162245
[TBL] [Abstract][Full Text] [Related]
17. Anti-Ro/SSA and La/SSB antibodies.
Franceschini F; Cavazzana I
Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
[TBL] [Abstract][Full Text] [Related]
18. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
[TBL] [Abstract][Full Text] [Related]
19. Isolated congenital complete heart block: longterm outcome of mothers, maternal antibody specificity and immunogenetic background.
Brucato A; Franceschini F; Gasparini M; De Juli E; Ferraro G; Quinzanini M; Vignati G; Bortolon C; Ghessi A; Pozzoli R
J Rheumatol; 1995 Mar; 22(3):533-40. PubMed ID: 7783076
[TBL] [Abstract][Full Text] [Related]
20. Anti-RO anti-LA anti-RNP antibodies and eletrocardiogram's PR interval in adult patients with systemic lupus erythematosus.
Costa M; Gameiro Silva MB; Silva JA; Skare TL
Acta Reumatol Port; 2008; 33(2):173-6. PubMed ID: 18604183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
